Does Emend Help with Delayed Chemotherapy Nausea?
Emend (fosaprepitant dimeglucamine, followed by oral aprepitant) prevents both acute and delayed nausea and vomiting from highly emetogenic chemotherapy like cisplatin. It targets the substance P/neurokinin-1 (NK1) receptor pathway, which plays a key role in delayed symptoms occurring 24-120 hours post-treatment.[1][2]
Clinical trials showed aprepitant reduced delayed nausea by 15-20% compared to placebo when added to ondansetron and dexamethasone. For example, in one study of 1,411 patients, complete response (no vomiting, minimal nausea) in the delayed phase was 68% with aprepitant versus 52% without.[3]
How Is Emend Typically Used for Nausea Prevention?
Emend is given as a single IV dose of 150 mg fosaprepitant on day 1, plus oral aprepitant 125 mg on day 1 and 80 mg on days 2-3. Guidelines from ASCO and NCCN recommend it for moderate-to-high emetogenic risk regimens, combined with 5-HT3 antagonists and steroids.[1][4]
What Do Real-World Studies Show for Delayed Nausea?
Post-approval data confirm efficacy: a meta-analysis of 20 trials found aprepitant cut delayed vomiting risk by 20% (RR 0.80). It works even in patients with prior poor control, though benefits are smaller for nausea alone versus vomiting.[5]
When Does It Not Work Well?
Emend is less effective for anticipatory nausea or vomiting from low-emetic-risk chemo. About 20-30% of patients still experience breakthrough symptoms, often needing rescue meds like olanzapine.[2][6]
How Does Emend Compare to Alternatives?
| Drug/Combo | Delayed Nausea Control | Key Differences |
|------------|-------------------------|-----------------|
| Emend + ondansetron + dex | 65-75% complete response | Strongest NK1 blocker; 3-day dosing |
| Rolapitant (Varubi) | Similar (RR 0.79) | Single dose; fewer drug interactions |
| Netupitant/palonosetron (Akynzeo) | 60-70% | Fixed combo; no steroid taper needed |
| Olanzapine add-on | Improves by 20-30% | Cheaper generic; sedating |
Emend outperforms placebo but matches rolapitant head-to-head.[7]
Common Patient Concerns and Side Effects
Patients report fatigue (15%), hiccups (10%), and constipation (10%) with Emend. It's pregnancy category B but avoided in severe liver issues. Cost runs $500-800 per cycle without insurance.[1][8]
[1]: Emend Prescribing Information (Merck)
[2]: DrugPatentWatch.com - Emend Patents
[3]: Hesketh et al., JCO 2003
[4]: NCCN Antiemesis Guidelines v2.2023
[5]: Hu et al., Ann Oncol 2014
[6]: Navari, J Support Oncol 2009
[7]: Schwartzberg et al., Ann Oncol 2015
[8]: Micromedex Drug Interactions